Original Cyclontane / ADK-638 patent trail
Patent disclosure · 2003
- What the patent describes
- Original Cyclontane/ADK-638 animal pharmacology, including treadmill groups of 8 preselected rats.
- What the source reports
- The later patent cites this earlier Cyclontane development record. Original behavioral and toxicity comparisons require direct verification before numerical claims are reproduced.
Reported patent results
Findings described in words
The patent reports increased running-to-exhaustion performance and stimulant-related behavioral effects.
Original Cyclontane/ADK-638 animal pharmacology, including treadmill groups of 8 preselected rats.
Population or model Original Cyclontane/ADK-638 animal pharmacology, including treadmill groups of 8 preselected rats.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Treadmill performance | Significantly longer running-to-exhaustion at selected tested exposures | 8 rats per group; exact table means not transcribed |
| Behavioral pharmacology | Anti-cataleptic activity and stimulant-like responses described | Model-specific comparisons do not establish human superiority to Bromantane |
Preselected animal performance is not a human occupational outcome, and the patent’s clinical recommendations exceed the experiments. Findings belong to ADK-638 rather than every related cage compound.
Source for these results ↗ · Reviewed 2026-11-06
Patent claims and provenance
Molecule. Cyclontane development patent; the compound identity is distinct from related cage amides and comparator agents.
A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.
- Publication
- RU2196575C2 ↗ · 2003-01-20
- Earliest priority / filing
- 1999-07-30 / 1999-07-30
- Original applicant / assignee
- Научно-исследовательский институт фармакологии РАМН
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 20223238 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Substance eliciting psychostimulating and antiasthenic effect
Inventors: С.Б. Середенин; И.С. Морозов; Г.Г. Незнамов; Н.В. Климова; Н.И. Авдюнина; И.А. Иванова; С.А. Сергеева; Г.И. Ковалев; Б.М. Пятин; Е.А. Вальдман; О.А. Михайлова; Н.А. Кисляк; О.В. Щербакова; О.Б. Степаненко; Е.А. Цветкова.
Study limitations and source details
Study limitations
- Bibliographic lead only; neither potency ratios nor toxicity estimates from secondary accounts are treated as verified here.
Source details
Prior-art citation followed from the 2018 patent; original retrieval unsuccessful.
Selected reported results and source limitations reviewed; not a complete risk-of-bias or experimental audit.
Sources checked
Citation
Author unconfirmed. Original Cyclontane / ADK-638 patent trail RU2196575C2; cited in later RU2674342C2